Resistin: A potential biomarker for periodontitis influenced diabetes mellitus and diabetes induced periodontitis

Disease Markers

Volumn 2014, Issue , 2014, Pages

  Devanoorkar, Archana ^a   Kathariya, Rahul ^b   Guttiganur, Nagappa ^a   Gopalakrishnan, D ^b   Bagchi, Paulami ^c  

^a AME's Dental College and Hospital ^*  (India)

^b DR D Y PATIL DENTAL COLLEGE AND HOSPITAL   (India)

^c DY Patil Dental School   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; INSULIN; INTERLEUKIN 1; INTERLEUKIN 6; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RECEPTOR TYROSINE KINASE LIKE ORPHAN RECEPTOR; RESISTIN; SECONDARY LYMPHOID TISSUE CHEMOKINE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; SUPPRESSOR OF CYTOKINE SIGNALING 3; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; ADIPOCYTOKINE; AUTACOID; BIOLOGICAL MARKER; RETN PROTEIN, HUMAN;

ADIPOCYTE; ADIPOGENESIS; ATHEROSCLEROSIS; CHRONIC KIDNEY DISEASE; CHRONIC PERIODONTITIS; DIABETES INDUCED PERIODONTITIS; DIABETES MELLITUS; HUMAN; INFLAMMATORY DISEASE; MACROPHAGE; MONOCYTE; PERIODONTITIS; PERIODONTITIS INFLUENCED DIABETES MELLITUS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYSTEMIC DISEASE; WHITE ADIPOSE TISSUE; ANIMAL; BLOOD; DIABETES MELLITUS, TYPE 2; IMMUNOLOGY; METABOLISM; OBESITY; PHYSIOLOGY; RISK FACTOR;

ADIPOKINES; ANIMALS; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 2; HUMANS; INFLAMMATION MEDIATORS; OBESITY; PERIODONTITIS; RESISTIN; RISK FACTORS;

EID: 84896958287     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2014/930206     Document Type: Review

References (54)

1. Zia A., Khan S., Bey A., Gupta N. D., Mukhtar-Un-Nisar S., Oral biomarkers in the diagnosis and progression of periodontal diseases. Biology and Medicine 2011 3 2 45 52
2. Holcomb I. N., Kabakoff R. C., Chan B., Baker T. W., Gurney A., Henzel W., Nelson C., Lowman H. B., Wright B. D., Skelton N. J., Frantz G. D., Tumas D. B., Peale F. V. Jr., Shelton D. L., Hébert C. C., FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. The EMBO Journal 2000 19 15 4046 4055 2-s2.0-0034254655
3. Steppan C. M., Bailey S. T., Bhat S., Brown E. J., Banerjee R. R., Wright C. M., Patel H. R., Ahima R. S., Lazar M. A., The hormone resistin links obesity to diabetes. Nature 2001 409 6818 307 312 2-s2.0-0035905758 10.1038/35053000
4. Pang S. S., Le Y. Y., Role of resistin in inflammation and inflammation-related diseases. Cellular & Molecular Immunology 2006 3 1 29 34 2-s2.0-33745171469
5. Graves D. T., Cochran D., The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. Journal of Periodontology 2003 74 3 391 401 2-s2.0-0038505147 10.1902/jop.2003.74.3.391
6. Nishimura F., Iwamoto Y., Mineshiba J., Shimizu A., Soga Y., Murayama Y., Periodontal disease and diabetes mellitus: the role of tumor necrosis factor- α in a 2-way relationship. Journal of Periodontology 2003 74 1 97 102 2-s2.0-0037261945 10.1902/jop.2003.74.1.97
7. Mengel R., Bacher M., Flores-de-Jacoby L., Interactions between stress, interleukin-1 β interleukin-6 and cortisol in periodontally diseased patients. Journal of Clinical Periodontology 2002 29 11 1012 1022 2-s2.0-0036835031 10.1034/j.1600-051X.2002.291106.x
8. Lehrke M., Reilly M. P., Millington S. C., Iqbal N., Rader D. J., Lazar M. A., An inflammatory cascade leading to hyperresistinemia in humans. PLoS Medicine 2004 1 161 168 2-s2.0-15744399190 10.1371/journal.pmed.0010045
9. Furugen R., Hayashida H., Yamaguchi N., Yoshihara A., Ogawa H., Miyazaki H., Saito T., The relationship between periodontal condition and serum levels of resistin and adiponectin in elderly Japanese. Journal of Periodontal Research 2008 43 5 556 562 2-s2.0-50849128821 10.1111/j.1600-0765.2008.01085.x
10. Taylor G. W., Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiologic perspective. Annals of Periodontology 2001 6 1 99 112 2-s2.0-0035757536
11. Pischon N., Heng N., Bernimoulin J.-P., Kleber B.-M., Willich S. N., Pischon T., Obesity, inflammation, and periodontal disease. Journal of Dental Research 2007 86 5 400 409 2-s2.0-34249310976 10.1177/154405910708600503
12. Pradeep A. R., Manjunath R. G., Kathariya R., Progressive periodontal disease has a simultaneous incremental elevation of gingival crevicular fluid and serum CRP levels. Journal of Investigative and Clinical Dentistry 1 2 133 138
13. Kathariya R., Jain H., Gujar D., Singh A., Ajwani H., Mandhyan D., Pentraxins as key disease markers for periodontal diagnosis. Disease Markers 2013 34 3 143 151
14. Pradeep A. R., Kathariya R., Raghavendra N. M., Sharma A., Levels of pentraxin-3 in gingival crevicular fluid and plasma in periodontal health and disease. Journal of Periodontology 2011 82 5 734 741 2-s2.0-79955632229 10.1902/jop.2010.100526
15. Pradeep A. R., Raghavendra R. N. M., Prasad M. V. R., Kathariya R., Patel S. P., Sharma A., Gingival crevicular fluid and serum visfatin concentration: their relationship in periodontal health and disease. Journal of Periodontology 2011 82 9 1314 1319 2-s2.0-80053025084 10.1902/jop.2011.100690
16. Raghavendra N. M., Pradeep A. R., Kathariya R., Sharma A., Rao N. S., Naik S. B., Effect of non surgical periodontal therapy on gingival crevicular fluid and serum visfatin concentration in periodontal health and disease. Disease Markers 2012 32 6 383 388
17. Sharma A., Pradeep A. R., Raghavendra N. M., Arjun P., Kathariya R., Gingival crevicular fluid and serum cystatin c levels in periodontal health and disease. Disease Markers 2012 32 2 101 107 2-s2.0-84858234168 10.3233/DMA-2011-0864
18. Devanoorkar A., Dwarakanath C. D., Gundanavar G., Patil S. R., Kathariya R., Evaluation of serum resistin levels in periodontal health and disease and effects of non-surgical periodontal therapy on its levels. Disease Markers 2012 32 5 289 294
19. Pradeep A. R., Kathariya R., Arjun Raju P., Sushma Rani R., Sharma A., Raghavendra N. M., Risk factors for chronic kidney diseases may include periodontal diseases, as estimated by the correlations of plasma pentraxin-3 levels: a case-control study. International Urology and Nephrology 2012 44 3 829 839 2-s2.0-79957641700 10.1007/s11255-011-9997-7
20. Pradeep A. R., Raghavendra N. M., Sharma A., Patel S. P., Raju A., Kathariya R., Rao N. S., Naik S. B., Association of serum and crevicular visfatin levels in periodontal health and disease with type 2 diabetes mellitus. Journal of Periodontology 2012 83 5 629 634 2-s2.0-84860495682 10.1902/jop.2011.110272
21. Steppan C. M., Lazar M. A., Resistin and obesity-associated insulin resistance. Trends in Endocrinology and Metabolism 2002 13 1 18 23 2-s2.0-0036134187 10.1016/S1043-2760(01)00522-7
22. Liu T., Baek H. A., Yu H., FIZZ2/RELM- β induction and role in pulmonary fibrosis. The Journal of Immunology 2011 187 1 450 461 10.4049/jimmunol.1000964
23. Rajala M. W., Obici S., Scherer P. E., Rossetti L., Adipose-derived resistin and gut-derived resistin-like molecule- β selectively impair insulin action on glucose production. The Journal of Clinical Investigation 2003 111 2 225 230 2-s2.0-0037241112 10.1172/JCI200316521
24. Steppan C. M., Lazar M. A., The current biology of resistin. Journal of Internal Medicine 2004 255 4 439 447 2-s2.0-1842506529 10.1111/j.1365-2796.2004. 01306.x
25. Filková M., Haluzík M., Gay S., Senolt L., The role of resistin as a regulator of inflammation: implications for various human pathologies. Clinical Immunology 2009 133 157 170
26. Sánchez-Solana B., Laborda J., Baladrón V., Mouse resistin modulates adipogenesis and glucose uptake in 3T3-L1 preadipocytes through the ROR1 receptor. Molecular Endocrinology 2012 26 1 110 127 2-s2.0-84855210399 10.1210/me.2011-1027
27. Gerstmayer B., Küsters D., Gebel S., Müller T., Van Miert E., Hofmann K., Bosio A., Identification of RELM γ a novel resistin-like molecule with a distinct expression pattern. Genomics 2003 81 6 588 595 2-s2.0-0037686319 10.1016/S0888-7543(03)00070-3
28. Tilg H., Moschen A. R., Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature Reviews Immunology 2006 6 10 772 783 2-s2.0-33748992313 10.1038/nri1937
29. Guzik T. J., Mangalat D., Korbut R., Adipocytokines-novel link between inflammation and vascular function? Journal of Physiology and Pharmacology 2006 57 4 505 528 2-s2.0-33846263404
30. Adeghate E., An update on the biology and physiology of resistin. Cellular and Molecular Life Sciences 2004 61 19-20 2485 2496 2-s2.0-9744274024 10.1007/s00018-004-4083-2
31. Muse E. D., Obici S., Bhanot S., Monia B. P., McKay R. A., Rajala M. W., Scherer P. E., Rossetti L., Role of resistin in diet-induced hepatic insulin resistance. The Journal of Clinical Investigation 2004 114 2 232 239 2-s2.0-4043082182 10.1172/JCI200421270
32. Satoh H., Nguyen M. T. A., Miles P. D. G., Imamura T., Usui I., Olefsky J. M., Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats. The Journal of Clinical Investigation 2004 114 2 224 231 2-s2.0-4043085036 10.1172/JCI200420785
33. Bajaj M., Suraamornkul S., Hardies L. J., Pratipanawatr T., DeFronzo R. A., Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients. International Journal of Obesity 2004 28 6 783 789 2-s2.0-2942515930 10.1038/sj.ijo.0802625
34. Sánchez-Solana B., Laborda J., Baladrón V., Mouse resistin modulates adipogenesis and glucose uptake in 3T3-L1 preadipocytes through the ROR1 receptor. Molecular Endocrinology 2012 26 1 110 127 2-s2.0-84855210399 10.1210/me.2011-1027
35. Sánchez-Solana B., Laborda J., Baladrón V., Mouse resistin modulates adipogenesis and glucose uptake in 3T3-L1 preadipocytes through the ROR1 receptor. Molecular Endocrinology 2012 26 1 110 127 2-s2.0-84855210399 10.1210/me.2011-1027
36. Zhou L., Li Y., Xia T., Feng S., Chen X., Yang Z., Resistin overexpression impaired glucose tolerance in hepatocytes. European Cytokine Network 2006 17 3 189 195 2-s2.0-33847674639
37. Utzschneider K. M., Carr D. B., Tong J., Wallace T. M., Hull R. L., Zraika S., Xiao Q., Mistry J. S., Retzlaff B. M., Knopp R. H., Kahn S. E., Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans. Diabetologia 2005 48 11 2330 2333 2-s2.0-27744545199 10.1007/s00125-005-1932-y
38. Ritchie C. S., Obesity and periodontal disease. Periodontology 2000 2007 44 1 154 163 2-s2.0-34247582450 10.1111/j.1600-0757.2007.00207.x
39. Field A. E., Coakley E. H., Must A., Spadano J. L., Laird N., Dietz W. H., Rimm E., Colditz G. A., Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Archives of Internal Medicine 2001 161 13 1581 1586 2-s2.0-0034917709
40. Wannamethee S. G., Shaper A. G., Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care 1999 22 8 1266 1272 2-s2.0-0032777687 10.2337/diacare.22.8.1266
41. Kaser S., Kaser A., Sandhofer A., Ebenbichler C. F., Tilg H., Patsch J. R., Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochemical and Biophysical Research Communications 2003 309 2 286 290 2-s2.0-0042925580 10.1016/j.bbrc.2003.07.003
42. Bokarewa M., Nagaev I., Dahlberg L., Smith U., Tarkowski A., Resistin, an adipokine with potent proinflammatory properties. Journal of Immunology 2005 174 9 5789 5795 2-s2.0-17844392652
43. Silswal N., Singh A. K., Aruna B., Mukhopadhyay S., Ghosh S., Ehtesham N. Z., Human resistin stimulates the pro-inflammatory cytokines TNF- α and IL-12 in macrophages by NF- B-dependent pathway. Biochemical and Biophysical Research Communications 2005 334 4 1092 1101 2-s2.0-23044439100 10.1016/j.bbrc.2005.06.202
44. Verma S., Li S., Wang C., Fedak P. W. M., Li R., Weisel R. D., Mickle D. A. G., Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 2003 108 6 736 740 2-s2.0-0043164953 10.1161/01.CIR.0000084503.91330.49
45. Hu W., Qiao S., Hou Q., Yuan J., Plasma resistin is increased in patients with unstable angina. Chinese Medical Journal 2007 120 10 871 875 2-s2.0-34249793672
46. Lee S. E., Kim H. S., Human resistin in cardiovascular disease. Journal of Smooth Muscle Research 2012 48 1 27 35
47. Cho Y., Lee S., Lee H., Hur J., Lee S., Youn S., Lee J., Lee H., Lee T., Park J., Hwang S., Kwon Y., Cho H., Oh B., Park Y., Kim H., Adipokine resistin is a key player to modulate monocytes, endothelial cells, and smooth muscle cells, leading to progression of atherosclerosis in rabbit carotid artery. Journal of the American College of Cardiology 2010 57 1 99 109 2-s2.0-78650536956 10.1016/j.jacc.2010.07.035
48. Yaturu S., Reddy R. D., Rains J., Jain S. K., Plasma and urine levels of resistin and adiponectin in chronic kidney disease. Cytokine 2007 37 1 1 5 2-s2.0-34147191611 10.1016/j.cyto.2007.02.003
49. Page R. C., The role of inflammatory mediators in the pathogenesis of periodontal disease. Journal of Periodontal Research 1991 26 3 230 242 2-s2.0-0025811915
50. Page R. C., The pathobiology of periodontal diseases may affect systemic diseases: inversion of a paradigm. Annals of Periodontology 1998 3 1 108 120 2-s2.0-0032112772
51. Scannapieco F. A., Position paper of The American Academy of Periodontology: periodontal disease as a potential risk factor for systemic diseases. Journal of Periodontology 1998 69 7 841 850 2-s2.0-0032110478
52. Saito T., Yamaguchi N., Shimazaki Y., Hayashida H., Yonemoto K., Doi Y., Kiyohara Y., Iida M., Yamashita Y., Serum levels of resistin and adiponectin in women with periodontitis: the hisayama study. Journal of Dental Research 2008 87 4 319 322 2-s2.0-42449159356 10.1177/154405910808700416
53. Hiroshima Y., Bando M., Inagaki Y., Mihara C., Kataoka M., Murata H., Shinohara Y., Nagata T., Kido J., Resistin in gingival crevicular fluid and induction of resistin release by Porphyromonas gingivalis lipopolysaccharide in human neutrophils. Journal of Periodontal Research 2012 47 5 554 562 2-s2.0-84856576830 10.1111/j.1600-0765.2011.01466.x
54. Zimmermann G. S., Bastos M. F., Dias Gonçalves T. E., Chambrone L., Duarte P. M., Local and circulating levels of adipocytokines in obese and normal weight individuals with chronic periodontitis. Journal of Periodontology 2013 84 5 624 633